Who owns Bicara Therapeutics Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BCAX from SEC Form 13F filings across 169 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 169 institutions disclosed 69.3M shares of Bicara Therapeutics Inc. worth $1.26B — about 101.3% of shares outstanding; the largest disclosed holder is RA CAPITAL MANAGEMENT, L.P.. Source: SEC Form 13F filings, parsed by EvidInvest.
169
13F holders
$1.26B
value, 2026 filers
101.3%
of shares outstanding (69.3M sh)
28
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of BCAX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | 7.3M | $135.0M | 1.4% | 10.6% | 0.0% |
| 2 | Vestal Point Capital, LP | 5.5M | $102.8M | 2.7% | 8.1% | +5.2% |
| 3 | Siren, L.L.C. | 5.5M | $102.4M | 2.4% | 8% | -1.8% |
| 4 | Deep Track Capital, LP | 4.1M | $76.3M | 1.2% | 6% | 0.0% |
| 5 | BlackRock, Inc. | 3.9M | $73.4M | 0.0% | 5.8% | +2.5% |
| 6 | TPG GP A, LLC | 3.0M | $56.0M | 1.4% | 4.4% | 0.0% |
| 7 | RED TREE MANAGEMENT, LLC | 2.9M | $54.4M | 46.6% | 4.3% | -7.7% |
| 8 | T. Rowe Price Investment Management, Inc. | 2.8M | $52.2M | 0.0% | 4.1% | -55.8% |
| 9 | Janus Henderson Group Ltd.NEW | 2.8M | $52.0M | 0.0% | 4.1% | new |
| 10 | FRANKLIN TEMPLETON INC | 2.7M | $23.7M | 0.0% | 3.9% | +36.5% |
| 11 | VANGUARD CAPITAL MANAGEMENT LLC | 2.2M | $41.2M | 0.0% | 3.2% | -0.1% |
| 12 | STATE STREET CORP | 2.1M | $38.3M | 0.0% | 3% | +0.4% |
| 13 | PRICE T ROWE ASSOCIATES INC /MD/ | 1.9M | $35.7M | 0.0% | 2.8% | +0.6% |
| 14 | Omega Fund Management, LLC | 1.8M | $32.8M | 26.2% | 2.6% | -3.4% |
| 15 | FMR LLC | 1.6M | $29.4M | 0.0% | 2.3% | -16.5% |
| 16 | GEODE CAPITAL MANAGEMENT, LLC | 1.2M | $21.9M | 0.0% | 1.7% | +1.4% |
| 17 | Jones Hill Capital LP | 1.1M | $19.8M | 3.4% | 1.6% | +19.2% |
| 18 | CITADEL ADVISORS LLC | 1.0M | $19.2M | 0.0% | 1.5% | +387.8% |
| 19 | Bellevue Group AGNEW | 720,483 | $13.4M | 0.3% | 1.1% | new |
| 20 | JPMORGAN CHASE & CO | 716,481 | $13.3M | 0.0% | 1% | -29.5% |
| 21 | Palo Alto Investors LP | 689,344 | $12.8M | 1.9% | 1% | +25.2% |
| 22 | ACORN CAPITAL ADVISORS, LLC | 668,381 | $12.4M | 3.4% | 1% | +3.9% |
| 23 | DIMENSIONAL FUND ADVISORS LP | 656,915 | $12.2M | 0.0% | 1% | +42.3% |
| 24 | Point72 Asset Management, L.P.NEW | 627,108 | $11.7M | 0.0% | 0.9% | new |
| 25 | MILLENNIUM MANAGEMENT LLC | 591,022 | $11.0M | 0.0% | 0.9% | +125.4% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.